TrialThe New England journal of medicine2023
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
A Michael Lincoff et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,350 papers cite itlatest 60 shown
this paperpooled ittrialcites it